Inflammation plays an important role in the development
of sepsis–acute
respiratory distress syndrome (ARDS). Olink inflammation-related biomarker
panels were used to analyze the levels of 92 inflammation-related
proteins in plasma with sepsis–ARDS (n = 25)
and healthy subjects (n = 25). There were significant
differences in 64 inflammatory factors, including TNFRSF11B in sepsis–ARDS,
which was significantly higher than that in controls. Functional analysis
showed that TNFRSF11B was closely focused on signal transduction,
immune response, and inflammatory response. The TNFRSF11B level in
sepsis–ARDS plasma, LPS-induced mice, and LPS-stimulated HUVECs
significantly increased. The highest plasma concentration of TNFRSF11B
in patients with sepsis–ARDS was 10–20 ng/mL, and 10
ng/mL was selected to stimulate HUVECs. Western blot results demonstrated
that the levels of syndecan–1, claudin–5, VE–cadherin,
occludin, aquaporin–1, and caveolin–1 in TNFRSF11B-stimulated
HUVECs decreased, whereas that of connexin-43 increased in TNFRSF11B-stimulated
HUVECs. To the best of the authors’ knowledge, this study was
the first to reveal elevated TNFRSF11B in sepsis–ARDS associated
with vascular endothelial dysfunction. In summary, TNFRSF11B may be
a new potential predictive and diagnostic biomarker for vascular endothelium
damage in sepsis–ARDS.